Hydralazine Hydrochloride Tablet
Product Images NDC 68071-2055

2 FDA label images from Nucare Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 68071-2055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0801cbcc-figure-01 (0801cbcc Figure 01)

0801cbcc-figure-01 (0801cbcc Figure 01)
Chemical structure of Hydralazine Hydrochloride showing its molecular framework including imidazole and hydrazine groups, along with an associated hydrochloride (HCl) molecule.*
FDA Label Image

Pdp (68071 2055)

Pdp (68071 2055)
Label for Hydralazine Hydrochloride 10 mg oral tablets from NuCare Pharmaceuticals, Inc. The label indicates package contains 30 tablets, each with 10 mg hydralazine HCl. Tablet is described as round orange, debossed with 'H' on one side and '38' on the other. Includes warnings and storage instructions, NDC 68071-2055-3, Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.